140.
Bjorntorp P. Obesity / P. Bjorntorp // Lancet. – 1997. – Vol. 350, № 9075. – P.
423-426.
141.
Body mass index and the prevalence of hypertension and dyslipidemia / C. D.
et al.] // Obes. Res. – 2000. – Vol. 8, № 9. – Р. 676-677.
142.
Body mass index, abdominal adiposity and blood pressure: consistency of their
association across developing and developed countries / S. Doll [et al.] // Int. J.
Obesity. – 2002. – Vol. 26, № 1. – P.48-57.
143.
Brown S. B. Phagocytosis triggers macrophage release of Fas-ligand and
induces apoptosis of bystander leukocytes / S. B. Brown, J. Savil // J. Immunol. –
1999. – Vol. 162. – P. 480-485.
144.
Cardiovascular and sympathetic effects of leptin / K. Rahmouni [et al.] // Curr.
Hypertens. Rep. – 2004. – Vol. 4. – P. 119-125.
145.
Cardiovascular morbidity and mortality associated with the metabolic
syndrome / B. Isomaa [et al.] // Diabetes Care. – 2001. – Vol. 24. – P. 683-689.
146.
Cardiovascular responsibility to stress in adolescents with and without
persistently elevated blood pressure / P. G. Saab [et al.] // J. Hypertens. – 2001. –
Vol. 19. – P. 21-27.
147.
Carlberg B. Atenolol in hypertension: is it a wise choice? / B. Carlberg, O.
Samuelsson, L. H. Lindholm // Lancet. – 2004, Vol. 364, № 9446. – P. 1684-
1689.
148.
Celermajer D. S. Endothelium-dependent dilation in the systemic arteries of
asymptomatic subjects relates to coronary risk factors and their interaction / D. S.
Celermajer, K. E. Sorensen, C. Bull // J. Am. Coll. Cardiol. – 1994. – Vol. 24. – P.
1468-1474.
149.
Cellular adhesion molecules in healthy subjects: short term variations and
relations to flow mediated dilation / O. Eschen [et al.] // Biomark. Insights. –
2008. – Vol. 3. – P. 57-62.
